What question did this study set out to answer?

The research aims to investigate how CLC3 affects V-ATPase activity and its implications for cisplatin resistance in cervical cancer cells.

April 17, 2026Cell Death Discovery0 citationsOpen Access

Correction: CLC3 regulates V-ATPase to enhance lysosomal degradation and cisplatin resistance in cervical cancer cells

CCChuyun ChenGuangzhou University of Chinese Medicine FZFubin ZhangNingbo University Affiliated Hospital JSJiaYi ShenNingbo University

Key Points

The research aims to investigate how CLC3 affects V-ATPase activity and its implications for cisplatin resistance in cervical cancer cells.
Conducted preliminary experiments in 24-well plates
Conducted formal experiments in 6-well plates
Analyzed the effects of CLC3 on lysosomal degradation and cisplatin resistance.
Formal results reaffirmed the conclusion despite experimental differences
CLC3 is involved in enhancing lysosomal degradation
Cisplatin resistance is linked to the activity of V-ATPase regulated by CLC3.

Abstract

preliminary experiments conducted using 24-well plates, which were not the formal experiments.The formal experiments should have been conducted using 6-well plates.Therefore, we replaced the formal experimental results, and this result had no impact on the conclusion of the article.

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper